药明康德公告称,公司已完成2025年第二次股份回购,实际回购股数为15,775,377股,占总股本的0.5462%,回购金额为1,000,001,057.93元。回购股份将全部用于注销并减少注册资本。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.